MTOR and neoplasm: The core of management for these patients lies in “comprehensive preoperative screening for HHT-related visceral AVMs and cardiac function assessment, intraoperative tailored management of vascular anatomical variations, and a postoperative regimen incorporating mTOR inhibitors with dual monitoring for AVM and tumor recurrence (14).” Through standardized perioperative management, this case achieved stable graft function and control of HHT.